Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Large-scale testing (Phase 3)UnknownNCT04610541
What this trial is testing

REMdesivir-HU Clinical Study and Severe Covid-19 Patients

Who this might be right for
SARS-CoV-2 Infection
University of Pecs 2,000
Large-scale testing (Phase 3)UnknownNCT04952805
What this trial is testing

Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

Who this might be right for
Covid19
Toscana Life Sciences Sviluppo s.r.l. 800
Large-scale testing (Phase 3)UnknownNCT04669015
What this trial is testing

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
Genova Inc. 914
Testing effectiveness (Phase 2)Study completedNCT04900337
What this trial is testing

Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.

Who this might be right for
Covid19
Amorphical Ltd. 66
Early research (Phase 1)UnknownNCT04747574
What this trial is testing

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Who this might be right for
SARS-CoV-2
Tel-Aviv Sourasky Medical Center 35
Not applicableStudy completedNCT04492501
What this trial is testing

Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan

Who this might be right for
Covid19Cytokine Release SyndromeCritical Illness+1 more
UNICEF 600
Post-approval studies (Phase 4)Study completedNCT04952857
What this trial is testing

Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease

Who this might be right for
Covid19
Post Graduate Institute of Medical Education and Research, Chandigarh 90
Large-scale testing (Phase 3)Study completedNCT04603729
What this trial is testing

Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease

Who this might be right for
Covid 19 Disease
Fatima Memorial Hospital 100
Not applicableStudy completedNCT04349618
What this trial is testing

Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia

Who this might be right for
Acute Respiratory Distress SyndromeCOVID19Sars-CoV2+1 more
Hospices Civils de Lyon 220
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Not applicableStudy completedNCT05083130
What this trial is testing

Awake Prone Positioning in Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV2 InfectionCOVID-19 Acute Respiratory Distress Syndrome+2 more
Oxford University Clinical Research Unit, Vietnam 93
Testing effectiveness (Phase 2)UnknownNCT04977960
What this trial is testing

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 180
Not applicableStudy completedNCT04392973
What this trial is testing

FAvipiravir and HydroxyChloroquine Combination Therapy

Who this might be right for
COVID19
King Abdullah International Medical Research Center 268
Testing effectiveness (Phase 2)Study completedNCT04343768
What this trial is testing

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Large-scale testing (Phase 3)Ended earlyNCT04492358
What this trial is testing

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Who this might be right for
Covid19
Maria Joyera Rodríguez 54
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Large-scale testing (Phase 3)Study completedNCT04600895
What this trial is testing

The Prevent Severe COVID-19 (PRESECO) Study

Who this might be right for
Covid19
Appili Therapeutics Inc. 1,187
Testing effectiveness (Phase 2)WithdrawnNCT04452097
What this trial is testing

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

Who this might be right for
COVID-19ARDSAcute Respiratory Distress Syndrome
Baylx Inc.
Next Page